Global /Australia /Healthcare /Medical Devices /RSH

Respiri Ltd.

RSH

• ASX: RSH • Delayed

0.0330AUD -3%

0.0235 USD

As of 5 June 2026, Respiri Ltd. has a market cap of $37.1M USD, ranking #32746 globally and #855 in Australia. It ranks #2952 in the Healthcare sector, and #616 in the Medical Devices industry.

Global Rank

32746

Country Rank

855

Sector Rank

2952

Industry Rank

616

Key Stats

Market Cap

$37.1MUSD

51.98M AUD

Enterprise Value

$36.27MUSD

50.82M AUD

Revenue (TTM)

$1.32MUSD

1.85M AUD

EBITDA (TTM)

-$5.44MUSD

-7.62M AUD

Net Income (TTM)

-$5.41MUSD

-7.58M AUD

PS Ratio

28.0

PB Ratio

10.8

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Marjan Mikel open_in_new

Employees

Founded

1987

Website

respiri.co open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3%	-11%	-18%	-54%	-51%	-60%	-5.7%	-44%	-51%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	RSH Respiri Ltd ISIN: AU000000RSH4 Shares Out.: Shares Outstanding: 1.575B¹ Shares Float: 1.407B² TV: TradingView: ASX: RSH SA: Stock Analysis: ASX: RSH YF: Yahoo Finance: RSH.AX GF: Google Finance: ASX: RSH BA: Barron's: RSH MS: Morningstar: XASX: RSH	0.0330 AUD	TV: TradingView: ASX: RSH SA: Stock Analysis: ASX: RSH YF: Yahoo Finance: RSH.AX GF: Google Finance: ASX: RSH BA: Barron's: RSH MS: Morningstar: XASX: RSH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Respiri Ltd.

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 11K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 7K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 2K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 2K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 361%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 359%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 467K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 433K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 429K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 341K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 325K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 275K%	22.2	Ireland

chevron_leftBack